Alternate Dosing Schedules Study for HPV Vaccine
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Alternate Dosing Schedules Study for HPV Vaccine is a clinical trial[1].
Key Facts
- Alternate Dosing Schedules Study for HPV Vaccine is in the country of United States[2].
- Alternate Dosing Schedules Study for HPV Vaccine's instance of is recorded as clinical trial[3].
- Alternate Dosing Schedules Study for HPV Vaccine's start time is recorded as +2009-03-31T00:00:00Z[4].
- Alternate Dosing Schedules Study for HPV Vaccine's end time is recorded as +2012-09-30T00:00:00Z[5].
- Alternate Dosing Schedules Study for HPV Vaccine's sponsor is recorded as Duke University[6].
- Alternate Dosing Schedules Study for HPV Vaccine's main subject is recorded as human papillomavirus infection[7].
- Alternate Dosing Schedules Study for HPV Vaccine's number of participants is recorded as {'unit': '1', 'amount': '+72'}[8].
- Alternate Dosing Schedules Study for HPV Vaccine's title is recorded as Alternate Dosing Schedules Study for HPV Vaccine[9].
- Alternate Dosing Schedules Study for HPV Vaccine's short name is recorded as ADS[10].
- Alternate Dosing Schedules Study for HPV Vaccine's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+9'}[11].
- Alternate Dosing Schedules Study for HPV Vaccine's ClinicalTrials.gov ID is recorded as NCT00862810[12].
- Alternate Dosing Schedules Study for HPV Vaccine's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[13].
- Alternate Dosing Schedules Study for HPV Vaccine's clinical trial phase is recorded as phase IV clinical trial[14].
- Alternate Dosing Schedules Study for HPV Vaccine's research subject recruitment status is recorded as completed[15].
- Alternate Dosing Schedules Study for HPV Vaccine's study type is recorded as interventional study[16].